Dr.Finance S.A. (WSE:DRF)
Poland · Delayed Price · Currency is PLN 1.510
+0.010 (0.67%)
At close: Aug 27, 2026
Dr.Finance Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.71 | 4.53 | 10.25 | 6.21 | 7.46 | 11.74 | |
Revenue Growth | -91.93% | -55.85% | 64.98% | -16.71% | -36.45% | 52.02% |
Cost of Revenue | 0.05 | 0.19 | 0.43 | 0.26 | 0.33 | 0.48 |
Gross Profit | 0.66 | 4.34 | 9.82 | 5.95 | 7.13 | 11.26 |
Selling, General & Admin | 1.01 | 4.62 | 9.94 | 5.94 | 7.24 | 10.98 |
Other Operating Expenses | 0.02 | -0.01 | 0.06 | 0.03 | 0.1 | 0.08 |
Operating Expenses | 1.03 | 4.61 | 10 | 5.98 | 7.35 | 11.07 |
Operating Income | -0.37 | -0.27 | -0.18 | -0.02 | -0.22 | 0.19 |
Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 |
Interest & Investment Income | - | - | 0 | 0 | 0 | 0 |
Other Non Operating Income (Expenses) | -0 | -0 | -0 | -0 | -0 | -0.01 |
EBT Excluding Unusual Items | -0.37 | -0.27 | -0.18 | -0.02 | -0.22 | 0.19 |
Gain (Loss) on Sale of Investments | 0.07 | 0.07 | -0.06 | - | - | 0.01 |
Other Unusual Items | - | - | - | - | - | 0 |
Pretax Income | -0.3 | -0.2 | -0.24 | -0.02 | -0.22 | 0.2 |
Income Tax Expense | 0 | 0 | - | 0 | - | 0.05 |
Net Income | -0.3 | -0.2 | -0.24 | -0.02 | -0.22 | 0.15 |
Net Income to Common | -0.3 | -0.2 | -0.24 | -0.02 | -0.22 | 0.15 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 |
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | -0.08 | -0.05 | -0.07 | -0.01 | -0.06 | 0.04 |
EPS (Diluted) | -0.08 | -0.05 | -0.07 | -0.01 | -0.06 | 0.04 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.32 | -0.25 | 0.09 | -0.19 | -0.19 | 0.05 |
Free Cash Flow Per Share | -0.09 | -0.07 | 0.02 | -0.05 | -0.05 | 0.01 |
Gross Margin | 92.96% | 95.88% | 95.77% | 95.82% | 95.56% | 95.94% |
Operating Margin | -51.46% | -5.95% | -1.76% | -0.35% | -2.90% | 1.66% |
Profit Margin | -42.22% | -4.52% | -2.38% | -0.38% | -2.97% | 1.27% |
Free Cash Flow Margin | -45.46% | -5.58% | 0.85% | -3.00% | -2.49% | 0.41% |
EBITDA | -0.37 | -0.27 | -0.18 | -0.02 | -0.21 | 0.2 |
EBITDA Margin | -51.39% | -5.94% | -1.74% | -0.27% | -2.82% | 1.72% |
D&A For EBITDA | 0 | 0 | 0 | 0 | 0.01 | 0.01 |
EBIT | -0.37 | -0.27 | -0.18 | -0.02 | -0.22 | 0.19 |
EBIT Margin | -51.46% | -5.95% | -1.76% | -0.35% | -2.90% | 1.66% |
Effective Tax Rate | - | - | - | - | - | 24.54% |
Revenue as Reported | 0.71 | 4.53 | 10.25 | 6.21 | 7.46 | 11.74 |